213
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Reimbursement and Adoption of Advanced Therapies: The 5-C Framework

Pages 573-578 | Published online: 05 Nov 2014
 

Acknowledgements

The author would like to thank the following for helpful discussion: Dr Cathy Prescott (Biolatris), Mr James Palmer (NHS England), Marg Parton, Dr Claire Packer (NIHR Horizon Scanning Centre), Dr Jonathan Howell (NHS England), Dr Alex Faulkner (University of Sussex), Rebecca Walker (ICON Pricing & Market Access), Dr Edmund Jessop (NHS England), Dr Virginia Warren (BUPA) and Joanna Murphy (NHS England).

Financial & competing interests disclosure

Asklepian Consulting Limited offers consultancy in the subject matter discussed in the manuscript. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.